Kadant vs Standex International
KAI and SXI side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KAI and SXI compare
Kadant is the larger company, worth 1.2 times as much as Standex International ($3.6B against $3.0B).
On earnings, Standex International is cheaper: it trades at 26.2× trailing earnings, against 30.5× for Kadant.
Kadant grew revenue faster over the last twelve months (16.6% versus 8.3% for Standex International).
Standex International keeps more of each dollar of sales as profit, with a net margin of 12.5% compared with 9.8% at Kadant.
Both pay dividends: Kadant yields 0.47% and Standex International 0.42%.
Kadant scores higher on the StockData Score (19 against 18 for Standex International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KAI | SXI |
|---|---|---|
| Size and price | ||
| Market cap | $3.6B | $3.0B |
| Share price | $302.17 | $245.63 |
| Change, 1 year | 13.6% | 3.2% |
| Change, 5 years | 28.7% | 116% |
| Beta (5Y) | 1.00 | 0.95 |
| Employees | 3,900 | 4,100 |
| StockData Score | ||
| Total score | 19 (better) | 18 |
| Valuation score | 3 | 4 (better) |
| Growth score | 3 | 3 |
| Performance score | 4 | 5 (better) |
| Health score | 5 (better) | 3 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 30.5× | 26.2× (better) |
| P/S | 3.0× (better) | 3.3× |
| P/B | 3.4× (better) | 3.8× |
| EV/EBITDA | 15.9× | 13.9× (better) |
| P/FCF | 20.5× (better) | 47.2× |
| FCF yield | 4.9% (better) | 2.1% |
| Fair value | $294.68 | $250.30 |
| Margin of safety | −2.5% | 1.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 16.6% (better) | 8.3% |
| Revenue growth, 5Y average | 10.6% (better) | 6.3% |
| Net income growth (TTM) | 14.8% | 116% (better) |
| EPS growth (TTM) | 14.5% | 115% (better) |
| EPS growth, 5Y average | 12.6% | 23.9% (better) |
| Profitability | ||
| Gross margin | 44.4% (better) | 42.4% |
| Operating margin | 15.4% | 22.5% (better) |
| Net margin | 9.8% | 12.5% (better) |
| FCF margin | 14.6% (better) | 6.9% |
| Return on equity | 11.7% | 15.3% (better) |
| Return on invested capital | 10.8% | 13.8% (better) |
| Financial health | ||
| Debt / equity | 0.43 (better) | 0.67 |
| Net debt / EBITDA | 1.31 (better) | 1.65 |
| Interest coverage | 8.9× (better) | 7.0× |
| Current ratio | 2.49 | 3.19 (better) |
| Altman Z-score | 4.60 | 4.77 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.47% (better) | 0.42% |
| Payout ratio | 14.1% | 14.4% |
| Years of dividend growth | 13 (better) | 1 |
| Dividend growth, 5Y average | 7.2% | 7.3% (better) |
| Buyback yield | −0.07% | 0.17% (better) |
| Shareholder yield | 0.40% | 0.58% (better) |
| Ownership | ||
| Held by institutions | 111% | 105% |
| Held by insiders | 1.2% | 1.8% |
| Insider net buying, 12 months | −$861K (better) | −$9.6M |
| Short interest, % of float | 6.8% | 5.1% |
Go deeper
- KAI stock overview
- KAI income statement
- KAI valuation and score
- SXI stock overview
- SXI income statement
- SXI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.